OCL 503

· IMBiotechnologies Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for OCL 503, covering 2018-09-07 to 2018-09-07. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Effectiveness of OCL 503 in the Treatment of Women With Leiomyomata [NA]